MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $304,000 | -66.6% | 8,600 | -67.8% | 0.01% | -65.0% |
| Q4 2014 | $909,000 | -56.7% | 26,700 | -50.9% | 0.02% | -55.6% |
| Q3 2014 | $2,097,000 | -36.4% | 54,365 | -35.8% | 0.04% | -54.5% |
| Q2 2014 | $3,297,000 | +216.1% | 84,700 | +177.7% | 0.10% | +200.0% |
| Q1 2014 | $1,043,000 | +73.3% | 30,500 | +6.3% | 0.03% | +32.0% |
| Q4 2013 | $602,000 | +28.1% | 28,700 | +43.5% | 0.02% | +25.0% |
| Q3 2013 | $470,000 | -26.6% | 20,000 | -16.0% | 0.02% | -31.0% |
| Q2 2013 | $640,000 | – | 23,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |